Skip to content

Study · Not a test of the peptide alone · 2008

1 result

Corticotropin-releasing hormone mediates alpha-melanocyte-stimulating hormone-induced anorexigenic action in goldfish.

Matsuda K, Kojima K, Shimakura S, Wada K, Maruyama K, Uchiyama M, Kikuyama S, Shioda S

Peptides8 Jul 2008Cited by 52 (Europe PMC)

PMID18656512 (opens in a new tab)DOI10.1016/j.peptides.2008.06.028 (opens in a new tab)PepBankPUB-18656512
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Melanotan II.

  1. 01AnimalNot a test of Melanotan II aloneAnimal study (in vivo)Mechanism

    In goldfish, a CRH 1/2 receptor antagonist abolished the inhibitory effect of intracerebroventricular MT II on food intake.

    In plain wordsIn goldfish, blocking CRH receptors removed the eating-suppressing effect of melanotan II.

    Peptide
    Melanotan II
    Outcome
    Not applicableAnorexigenic effect of MT II after CRH receptor blockade
    Study

    goldfishn: not reported in source

    Outcome group
    Appetite and food intake · Metabolic and weight

    Source sentences

    Summary
    The inhibitory effect of ICV injection of the alpha-MSH agonist, melanotan II (MT II), on food intake was abolished by treatment with a CRH 1/2 receptor antagonist, alpha-helical CRH((9-41))

    In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan II.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.